Ketogenic diet for recurrent brain tumors
Part of Cancer clinical trials.
This study tests whether a ketogenic diet (a diet very low in carbohydrates and high in fats) can help people with brain tumors that have come back after radiation. It looks at safety and how the diet affects the tumor, which might help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain tumor (glioma) that has come back after radiation therapy.
- You are scheduled for brain surgery (biopsy or removal of the tumor).
- You are 18 years or older and able to care for yourself (Karnofsky score 70 or higher).
- You are willing to follow a strict ketogenic diet during the study.
- You have adequate organ function (kidney, liver, blood counts) as determined by blood tests.
- You do not have diabetes (HbA1c < 6.5%) and are not on diabetes medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, shorter course of radiation therapy (called hypofractionation) for people with glioblastoma that has come back. It is for patients who have already had radiation and are doing well enough to consider another round.
This trial studies whether a very low-carbohydrate diet (a ketogenic diet) can help people with certain brain tumors. It’s meant as an added treatment alongside the usual care to see if it’s safe and potentially beneficial.
This trial tests whether a very low-carb, high-fat ketogenic diet helps people with newly diagnosed glioblastoma when combined with standard cancer treatment. You would compare this special diet guidance to the usual anti-cancer diet guidance while receiving the same standard-of-care treatments.
This early-phase trial tests whether two antifungal drugs, ketoconazole and posaconazole, can help treat recurrent high-grade gliomas when taken by mouth before surgery. The goal is to see if these drugs can reach the tumor and slow its growth.
This trial tests a combination of low-dose radiation, an immunotherapy drug (sintilimab), and chemotherapy (temozolomide) for people with glioblastoma that has come back. The goal is to see if this approach can help control the tumor and improve survival.
This trial tests an experimental drug, BMS-986504, for people with recurrent glioblastoma (a type of brain cancer). The drug targets a specific genetic change in the tumor. It aims to see if the drug can help shrink or slow the tumor.
Hear when a new Recurrent Glioma (Glioblastoma Multiforme) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.